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ABSTRACT
Introduction Despite global concerns about the safety 
and quality of health care, population- wide studies 
of hospital outcomes are uncommon. The SAFety, 
Effectiveness of care and Resource use among Australian 
Hospitals (SAFER Hospitals) study seeks to estimate the 
incidence of serious adverse events, mortality, unplanned 
rehospitalisations and direct costs following hospital 
encounters using nationwide data, and to assess the 
variation and trends in these outcomes.
Methods and analysis SAFER Hospitals is a cohort 
study with retrospective and prospective components. 
The retrospective component uses data from 2012 to 
2018 on all hospitalised patients age ≥18 years included 
in each State and Territories’ Admitted Patient Collections. 
These routinely collected datasets record every hospital 
encounter from all public and most private hospitals 
using a standardised set of variables including patient 
demographics, primary and secondary diagnoses, 
procedures and patient status at discharge. The study 
outcomes are deaths, adverse events, readmissions and 
emergency care visits. Hospitalisation data will be linked to 
subsequent hospitalisations and each region’s Emergency 
Department Data Collections and Death Registries to 
assess readmissions, emergency care encounters and 
deaths after discharge. Direct hospital costs associated 
with adverse outcomes will be estimated using data 
from the National Cost Data Collection. Variation in these 
outcomes among hospitals will be assessed adjusting 
for differences in hospitals’ case- mix. The prospective 
component of the study will evaluate the temporal change 
in outcomes every 4 years from 2019 until 2030.
Ethics and dissemination Human Research Ethics 
Committees of the respective Australian states and 
territories provided ethical approval to conduct this 
study. A waiver of informed consent was granted for 
the use of de- identified patient data. Study findings will 
be disseminated via presentations at conferences and 
publications in peer- reviewed journals.
INTRODUCTION
Modern hospital care is fast- paced, complex 
and expensive. While this care has undoubt-
edly led to advances in care for many patients, 
the Institute of Medicine report ‘To Err 
is Human’ highlighted an uncomfortable 
truth—modern care also leads to considerable 
harm with ~98 000 patient deaths attributed to 
medical error.1 In addition to deaths, patients 
experience high rates of adverse events, with 
a systematic review of pivotal studies2 from the 
Strengths and limitations of this study
 ► SAFety, Effectiveness of care and Resource use 
among Australian Hospitals is a population- wide 
study that uses routinely collected administrative 
data from all public and most (86%) private hospi-
tals in Australia to estimate the national incidence 
of serious adverse events, deaths and unplanned 
hospitalisations, and measure how these outcomes 
vary among hospitals.
 ► It will also use publicly available summary cost data 
to estimate the avoidable direct healthcare costs as-
sociated with adverse outcomes of care.
 ► It has retrospective and prospective components 
that will enable monitoring of temporal change in 
patient characteristics and outcomes over time.
 ► The major strength of this study is comprehensive 
data linkage enabling reporting of outcomes at a 
national scale including patient outcomes after 
discharge.
 ► The main limitation of the study is unmeasured 
confounding from the use of routinely collected ad-
ministrative data which is less granular than data 
collected solely for research, although a population- 
wide study on this scale would not be feasible with-
out using administrative data.
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USA, UK, Australia, New Zealand and Canada suggesting 
9.2% of hospitalised patients suffer an adverse event, 
with nearly half (43.5%) of these events deemed prevent-
able, despite these countries having advanced healthcare 
systems. Many of these adverse events occur after hospital 
discharge, for example, about 20% of patients experi-
ence an adverse event in the 1st month post- discharge,3 
a rate that is almost double the reported rate of in- hos-
pital adverse events. Large- scale population- wide studies, 
predominantly from North America, also suggest high 
rates of death and unplanned readmissions following 
hospitalisations,4 with these adverse outcomes being a 
major cause of avoidable healthcare costs.5 6 Moreover, 
these studies also show that patient outcomes vary two 
fold to three fold among hospitals for many common 
conditions,4 7 8 suggesting variations in quality of care.4 7
Healthcare outcomes in Australia
In Australia, far less is known about these harms because 
post- discharge outcomes of care are not systematically 
captured or analysed. More than 10 million hospitalisa-
tions occur annually in Australia for the treatment of a 
range of conditions across 1322 structurally diverse, and 
geographically dispersed, public and private hospitals 
(Figure 1) at a cost of >$A60 billion/year.9 The Quality 
in Australian Health Care Study, performed nearly two 
decades ago, found 16.6% of patients experienced an 
adverse event leading to disability or a longer hospital stay 
with half (51%) deemed preventable.10 The disability in 
13.7% patients was permanent and 4.9% of the patients 
died from a potentially preventable cause. Multiple subse-
quent studies show a persisting 6.9%–16.6%9–11 rates of 
adverse events among Australian hospitals,11 suggesting 
suboptimal patient safety. However, there are no large- 
scale national studies of post- discharge adverse events, 
deaths or unplanned readmissions in Australia. The lack 
of post- discharge outcome data in Australia means that 
adverse outcomes of hospital care, and the full impact 
of these events on patients and the health system, are 
substantially underestimated. The main barriers have 
been accessing hospitalisation data and the inability to 
link individual patient data across hospitals and with time 
to measure post- discharge outcomes on a national scale.
Direct healthcare costs associated with these adverse 
outcomes are also uncertain. In 2016–2017 health-
care cost Australia over $A112.0 billion, with 47.8% 
($A63.8 billion) of the total cost spent on public hospi-
tals, making hospitals the largest area of health expen-
diture.12 Preventable in- hospital complications alone 
are estimated to contribute $A1.5 billion to this cost.13 
However, little or no information currently exists about 
the resource impact of post- discharge outcomes on the 
Australian health system, meaning that the impact of 
adverse events and related avoidable healthcare costs 
are likely to be underestimated. For example, the cost of 
unplanned readmissions within 30 days in the US Medi-
care population has been estimated at US$17 billion per 
year,6 much of which is avoidable expenditure as many of 
these readmissions are preventable.14 Cost and resource 
Figure 1 Geographical distribution of hospitals throughout Australia. Approximately 70% of the Australian population are 
in densely populated major cities with the remainder distributed through sparsely populated regional and remote areas. 
There are more than 1322 public and private hospitals distributed throughout eight states and territories. Public hospitals 
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considerations are major drivers of decision- making for 
clinicians, health services and government. Compres-
sively quantifying avoidable healthcare expenditure in 
the Australian setting may, therefore, provide a strong 
catalyst for change, and may assist the development of 
cost- effective interventions to improve patient outcomes.
Public concerns also exist about unwarranted variation 
in processes of care among Australia hospitals although 
there are only a few studies that have examined vari-
ation in outcomes.11 15 16 While these studies focus on 
a limited number of conditions, they consistently show 
marked variation in use of treatments or procedures 
among hospitals which are not explained by variations 
in patient demographics, suggesting disparities in care. 
The Australian Productivity Commission,17 an indepen-
dent policy advisory body on a range of issues affecting 
the welfare of Australians, recommended reporting on 
basic outcome measures such as mortality and readmis-
sions to inform patients and build greater transparency 
and accountability, citing significant opportunities to 
improve healthcare efficiency. Similarly, the Austra-
lian Commission on Safety and Quality in Health Care 
(ACSQHC), has produced the Atlas of Healthcare Varia-
tion which has shown substantial geographical variation 
in use of healthcare across Australia.18 The commission 
has further proposed to report outcomes of care across 
public and private hospitals and make this information 
available to the public. Profiling hospital variations in 
outcomes allows rapid detection of ‘outlier’ hospitals 
with high adverse event rates, thereby providing a mech-
anism to rapidly intervene and minimise potential safety 
and quality problems. These methods can facilitate local 
quality improvement efforts by feedback of data to stim-
ulate hospitals to critically examine their outcomes, and 
when necessary, invest in infrastructure, protocols and 
other strategies to reduce adverse outcome rates over 
time. Lastly, profiling variation in outcomes promotes 
knowledge translation from positive deviation that is, 
learning from facilities with low adverse outcome rates to 
identify innovative strategies to improve care.
SAFER Hospitals: a national data linkage study
SAFety, Effectiveness of care and Resource use among 
Australian Hospitals (SAFER Hospitals) is a nationwide 
cohort study that, for the first time in Australia, brings 
together linked hospitalisation and outcome data from 
all Australian states and territories in addressing these 
knowledge gaps. Every Australian hospital collects data 
on all hospital encounters using a nationally standardised 
set of data definitions. Individual records can be linked 
within the datasets, and with others such as death regis-
tries, making it feasible to track important outcomes after 
hospitalisations.
The SAFER Hospitals study will create a national data 
collection to estimate hospital- wide incidence of outcomes 
of hospital- based care across all conditions, separating 
hospital- wide effects on patient outcomes from condition- 
specific effects. It will also assess the variation in these 
outcomes among hospitals, quantify the consequences of 
adverse outcomes on patients in the short- term and long- 
term, and assess their impact on healthcare systems with 
a focus on potentially avoidable health system costs and 
resources used.
The specific study aims are to
1. Assess the safety of hospital care by estimating the in-
cidence of serious adverse events and consequences of 
these adverse events on short- term and long- term pa-
tient outcomes.
2. Assess the effectiveness of hospital care by (a) esti-
mating the incidence of rehospitalisation (inpatient 
readmissions and emergency care encounters) and all- 
cause mortality post- hospitalisation; and by (b) quan-
tifying the proportion of these events that result from 
potentially preventable causes.
3. Assess healthcare costs and resource use associated 
with adverse outcomes defined in aims 1 and 2, and 
to estimate the proportion of costs and resources that 
may be avoidable.
4. Compare variation in serious adverse events, deaths 
and unplanned readmissions among hospitals using 
standardised methods that account for differences in 
hospitals’ case- mix and volume.
5. Develop and test the application of advanced compu-
tational methods such as machine learning in facilitat-
ing more accurate detection and prediction of adverse 
outcomes.
6. Prospectively evaluate the temporal change in specific 
outcomes of hospital care by periodically re- evaluating 
these outcomes until 2030.
METHODS AND ANALYSIS
Study design
A population- wide cohort study consisting of retro-
spective and prospective components, using routinely 
collected administrative data from all public and most 
(86%) private hospitals in Australia. Private hospital data 
are not available to researchers from South Australia, 
Northern Territory and Tasmania which collectively 
contain about 14% of all private hospitals in Australia.19 
Figure 2 outlines the study schema.
Study cohort
We include all hospitalised patients aged ≥18 years from 
each state and territory’s Admitted Patient Collections 
(APC) from 1 January 2012 to 31 December 2018. Each 
APC records all inpatient and same- day admissions from 
all public and most private sector hospitals and day proce-
dure centres. Patient data are collected using a stan-
dardised set of variables defined by the National Hospital 
Minimum Data set for admitted patient care.20 The infor-
mation collected in each APC includes patient sociode-
mographic characteristics, geographical region, source 
of referral to the service, acute and elective status of the 
encounter and service referred to on separation, primary 
and up to 50 secondary diagnoses and procedures, 
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external causes of injury and patient status at discharge. 
All diagnosis data are coded per International Classifi-
cation of Diseases and Related Problems, 10th revision 
Australian Modification (ICD-10- AM) and procedures are 
coded per the Australian Classification of Health Inter-
ventions. Validation audits against medical records have 
shown relatively good (>85%) accuracy of coded data.21
From the APCs, we include all hospitalised patients 
irrespective of condition, as the primary objective is to 
study hospital- wide outcomes (ie, across all conditions). 
Adverse outcomes of hospital care are frequently driven 
by broad hospital- wide phenomenon such as hospital 
quality control systems and discharge practices in addi-
tion to model of care factors related to the underlying 
condition. Consistent with prior population studies,11 22 
this approach allows evaluation of hospital- wide phenom-
enon separate from condition specific effects. Examining 
hospital- wide outcomes at the onset also enables a ‘top- 
down’ approach to subsequently examining condition- 
specific outcomes. To facilitate this, we will examine 
outcomes by the 23 Major Diagnostic Categories (MDCs) 
into which all patient diagnoses fall, with MDCs generally 
corresponding to the major organ systems of the body.
Patient comorbidities
Patient comorbidities are identified using the Condition 
Category (CC) clinical classification that groups ICD 
codes into clinically meaningful conditions using diag-
nosis and procedure codes from the index admission and 
from any hospitalisations in the preceding 12 months. 
We use the CC classification because it is widely used to 
derive comorbidities from routinely collected hospital 
data.23 While the CC model uses ICD-9- CM coding, we 
have developed an equivalent model based on ICD-10- AM 
coding for use with Australian data.24
Study outcomes
The primary study outcomes are adverse events, all- 
cause mortality, all- cause unplanned rehospitalisations 
(including unplanned inpatient readmissions and emer-
gency care encounters) and measures of healthcare 
costs occurring in hospital and after discharge. The 
study design enables short- term and long- term outcome 
assessment.
Adverse events
We define adverse events using the Classification of 
Hospital Acquired Diagnoses (CHADx) developed by 
ACSQHC using ICD-10- AM diagnosis codes. Adverse 
events are identified from the APC using these diagnosis 
codes and the condition onset flag to indicate that the 
adverse event occurred in hospital and was not a pre- 
existing condition prior to hospitalisation. The CHADx 
taxonomy can be further condensed to form a list of 16 
hospital- acquired conditions which identify the more 
common and serious adverse events that can be accu-
rately measured using routinely collected data. This 
was developed through a comprehensive process that 
included literature review, clinical engagement and vali-
dation using clinical data.
All-cause mortality
All deaths are determined by linking APC cohort records 
with each jurisdiction’s Registry of Deaths which record 
the cause and date of death including out- of- hospital 
deaths. Death occurring in hospital and within the 
Figure 2 Study schema of the SAFety, Effectiveness of care and Resource use among Australian Hospitals cohort, data 
sources and outcomes. The study cohort is selected from the Admitted Patient Collections of each state and then linked to 
subsequent data sources to measure outcomes.
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emergency department is recorded within the APC and 
the Emergency Department Data Collection (EDDC, see 
below), respectively.
All-cause unplanned rehospitalisations
All- cause rehospitalisations are defined as the composite 
outcome of inpatient readmissions and emergency depart-
ment presentations.6 14 Readmissions to any hospital after 
the index hospitalisation are measured by linking the 
study cohort records to subsequent records within each 
region’s APC. Emergency care visits will be assessed by 
linking hospitalisation records with each region’s EDDC. 
EDDC records all emergency department (ED) encoun-
ters using a standardised set of variables from all public 
and selected private hospitals with ED facilities, including 
source of referral, mode of presentation, triage category, 
primary ED diagnosis and the service referred to on 
separation.
We only count unplanned readmissions in the outcome 
of rehospitalisation as planned (elective) admissions for 
scheduled care are a part of normal care and are less 
likely to be related to care quality. We removed planned 
admissions from the outcome using the ‘Care type’ and 
‘Acute/elective’ admission status variables that identify 
acute care from non- acute and subacute encounters. 
Since emergency care is reserved for acute presentations, 
all emergency care visits are regarded as unplanned.
Direct costs and healthcare resource use
Direct costs associated with hospital care is estimated using 
publicly available summary cost data from the National 
Hospital Cost Data Collection (NHCDC).25 The NHCDC 
collates patient- level cost data from >400 public and private 
hospitals in Australia using standardised definitions and 
contains the average cost associated with hospitalisa-
tion for various conditions as defined by the Australian 
refined diagnostic- related group (DRG, derived from the 
principal diagnosis and procedures), the proportion of 
costs that are direct and indirect (overheads) and the 
components of the cost such as the average amount spent 
on beds, pharmacy, allied health and pathology. NHCDC 
also contains the average cost associated with ED encoun-
ters as defined by the urgency- related group (URG) for 
ED presentations. As NHCDC does not publish average 
DRG/URG costs from private hospitals, averages costs for 
these hospitals will be calculated using the average cost 
per DRG or URG of the public hospitals’ data in the same 
year and the ratio of the cost weight per DRG (or URG) 
between private and public hospitals.
Linkage of patient records within and across data-
sets is performed within each state or territory except 
where cross jurisdictional (across state) linkage is readily 
possible such as between New South Wales and the Austra-
lian Capital Territory, and South Australia and Northern 
Territory. All data linkages will be performed by desig-
nated Data Linkage Units within each jurisdiction using 
probabilistic matching using multiple patient identifiers 
(such as age, sex, date of birth and Medicare number) 
with reported accuracy exceeding 99%.26 27 Once linked, 
de- identified patient data are released to researchers. Data 
from each jurisdiction are then aggregated to compose a 
national dataset consisting of equivalent variables from 
each region. All datasets and linkage components are 
listed in the online supplemental appendix.
Analysis plan
Aim 1: Estimate the national incidence of serious adverse 
events, deaths and unplanned rehospitalisations occur-
ring in hospital and post- discharge.
The incidence of major outcomes of hospital care 
(adverse events, deaths, unplanned rehospitalisations) 
is separately estimated by calculating the proportion of 
all hospitalisations that experienced at least one outcome 
within 90 days of their initial hospitalisation expressed as a 
percentage of all hospitalisations. To describe the timing 
of these outcomes, we will use time- to- event analysis 
(Kaplan- Meier method and Cox Regression) to generate 
unadjusted and adjusted event- free survival curves at 
each time point. In survival models for adverse events 
and deaths, time will be measured as the number of days 
from admission until the first occurrence of the outcome. 
For rehospitalisations, time is measured from discharge 
in patients who are discharged alive. Patients will also 
be censored if they do not experience the outcome of 
interest or reach the end of the 90 day follow- up period. 
Outcomes will be assessed by geographical region and 
adjusted for temporal change in baseline characteristics 
to account for changes in underlying population charac-
teristics over time.
Aim 2: Assess the direct healthcare costs associated with 
these adverse outcomes and determine the proportion 
that may be avoidable.
The total cost associated with adverse events is defined 
as the composite of (1) the incremental cost associated 
with adverse events occurring in hospital and (2) the 
cost associated with one or more hospital encounters 
for adverse events occurring within the 90 days of the 
index admission. To estimate incremental cost of adverse 
events occurring in hospital, a generalised linear model 
with a log- link function and a gamma distribution28 will 
be used, adjusting for differences in baseline characteris-
tics between patients with and without an adverse event. 
The direct cost of post- discharge adverse events will be 
estimated by matching the DRG or URG associated with 
the episode of care to the average cost associated with the 
DRG or URG published in the NHCDC. For patients with 
more than one episode during the outcome time frame, 
costs will be summed to provide a total cost. All costs will 
be converted to current Australian dollars using health 
index deflators. Direct costs associated with unplanned 
rehospitalisations are estimated by matching the DRG or 
URG associated with the rehospitalisations to the average 
cost associated with the DRG published in the NHCDC 
in a similar manner to estimating costs associated with 
post- discharge adverse events. Costs will be assessed and 
compared by geographical region.
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To estimate the proportion of readmissions that may 
be avoidable, we will use a classification system previously 
used to identify readmissions that are potentially related 
to hospital care from coded data. While it is challenging 
to capture the exact reasons for readmissions from coded 
or clinical data, this classification system provides a 
reasonable approach in determining the extent to which 
a readmission is preventable or avoidable. We will clas-
sify each readmission into four groups: (1) due to adverse 
event; (2) for the same diagnosis as the index admission; 
(3) potentially related to the index diagnosis and (4) 
other (unrelated) conditions. Group 1 identifies read-
missions for hospital- acquired (iatrogenic) conditions 
such as pulmonary embolus and adverse drug events. 
This provides a conservative estimate of costs that are 
most avoidable. To a lesser extent, groups 2 and 3 (read-
missions for same or a related condition) also indicate 
opportunities to reduce cost by optimising patient care, 
although recognising that it is difficult to distinguish 
from re- admissions due to disease progression. Group 4 
represents cost due to unrelated readmissions, which are 
the least avoidable. All emergency care visits are deemed 
unplanned, and therefore avoidable, when estimating 
costs. We will then sum the total costs in each group 
representing the proportion of avoidable healthcare 
costs. Variation in costs will be assessed by geographical 
region. We will also explore the possibility of combining 
the four categories of hospital readmissions to create a 
robust overall index with the weighing of categories to be 
determined based on empirical testing, available litera-
ture and expert clinical opinion.
Aim 3: To detect unwarranted institutional variation in 
these outcomes among hospitals accounting for case- mix 
differences which may suggest variation in care quality.
To profile variation in patient outcomes among hospi-
tals, adjusting for differences in case- mix, we estimate 
each hospital’s risk- standardised outcome rate (RSOR) 
using a hierarchical generalised linear model (HGLM) 
that accounts for differences in the hospital case- mix, 
sample- size and clustering of patients within hospitals.
For hospital- wide analyses, there are published risk- 
adjustment models for different outcomes (eg, deaths, 
readmissions) for different clinical conditions that 
consider the complexity and diversity of procedures 
undertaken among hospitals. Such models do not typi-
cally estimate risk- standardised rates for one hospital- 
wide cohort as one model including all admissions 
would not account for differences in risk variables across 
different conditions. Instead, the risk models are based 
on a composite risk adjustment model that includes 
several subgroups of patients. For example, Horwitz et al7 
described the development and use of methods to profile 
hospital- wide 30- day unplanned readmissions. Here, all 
admissions are grouped into five cohorts made up of 
conditions or procedures with relatively similar readmis-
sion and post- discharge mortality rates, that are likely to 
be cared for by similar teams of clinicians and that would 
generate an adequate sample size for most hospitals. Risk 
adjustment models are developed within each cohort 
and a weighted score, based on the distribution among 
cohorts, is used to estimate an overall model. Similar 
composite risk- adjustment models are currently being 
developed for 30- day mortality.29 Our goal is to develop 
similar approaches to risk- adjustment for each outcome 
using Australian data.
The hospital specific RSOR is calculated as the ratio 
of predicted hospital outcomes over expected hospital 
outcome, multiplied by the crude national average 
outcome rate. The predicted number of outcomes is 
calculated based on the hospital’s case- mix and the esti-
mated hospital- specific intercept term. The expected 
number of outcomes is calculated based on the hospital’s 
case- mix and national average intercept. The ratio is then 
multiplied for each hospital by the overall crude outcome 
rate for ease of interpretation. Bootstrapping with 1000 
replications will be used to empirically construct a 95% 
CI estimate for each hospital’s RSOR using the percen-
tile method. A hospital is deemed a statistical outlier if 
the hospital’s entire 95% interval estimate is above or 
below the national average. This approach for estimation 
of the RSOR ensures that the observed variation among 
hospitals is not due to underlying differences in case- mix 
or procedure- mix and is consistent with methods we 
have previously used for profiling variation in outcomes 
among hospitals.15 30 All hospital- level analyses will be 
limited to unique hospitals with at least 25 hospitalisa-
tions during the study period to enable a robust estimate 
of the hospital outcome rate.
Aim 4: Test machine learning methods to better predict 
adverse outcomes of hospital care to inform service 
improvement initiatives.
This aim will test the accuracy of machine learning 
methods, compared with conventional regression 
models, for predicting adverse outcomes such as death 
and readmissions which may be useful in developing 
automated methods that identify high- risk individuals 
and facilitate service improvement. Machine learning, 
a subfield of artificial intelligence, refers to an array of 
data- driven automated analytical techniques that rely 
on sophisticated pattern- recognition methods, which 
can ‘learn’ from large- scale datasets. Machine learning 
is widely used in industry for rapid automated analysis 
of massive volumes of routinely collected data such as 
that collected in hospitals in the process of delivering 
care. While machine learning methods initially failed to 
suggest superiority over conventional statistical methods, 
more recent analyses suggest significantly better ability 
to predict outcomes from administrative datasets.31 32 
To achieve this goal, we will develop machine learning 
methods including deep learning that can automatically 
extract relevant features from data collected from hospi-
tals. We will train models using a five- fold cross valida-
tion experiment, where for each of the folds, a random 
set containing 80% of the dataset samples will be used 
for training and the remaining 20% will then be used 
for testing the model. All models will be compared with 
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a standard logistic regression model using the model 
c- statistic.
Aim 5: To prospectively evaluate the temporal change 
in each of the outcomes of hospital care by periodically 
re- evaluating these outcomes until 2030.
This prospective evaluation will assess how outcomes 
change with time at both the patient and hospital level. 
This aim will be achieved by prospectively extending the 
cohort every 4 years from 2019 until 2030 and comparing 
the longitudinal trend in each outcome using stan-
dardised methods. The Cochran- Armitage trend test or 
HGLM will be used to assess for statistically significant 
trends over time. Finally, the study results will be reported 
in accordance with the Strengthening the Reporting of 
Observational Studies in Epidemiology statement.33
Supplementary analyses
In most regions, de- identified data are provided for anal-
ysis including de- identified hospital labels where hospital 
names and unique identifiers are replaced with a dummy 
identifier so that hospital- level analyses are possible, but 
the hospital cannot be identified. In New South Wales, 
Queensland and Tasmania, actual hospital identifiers are 
provided. In these regions, we will seek to further examine 
the association of hospital- specific characteristics with the 
outcomes using publicly available data from the National 
Public Hospital Establishments Database (NPHED)34 and 
the MyHospitals35 reporting portal. Using standardised 
data definitions, NPHED collects data on each hospi-
tal's revenue, staffing levels, expenditure, the number 
of available beds for admitted patients, geographical 
location, specialised service indicators and the type 
of non- admitted patient care.34 NPHED data are only 
available for public hospitals. The MyHospitals national 
reporting platform allows users to explore information 
about hospitals and publicly reports a selected number 
of hospital- specific performance process and outcome 
indicators such as healthcare- associated infection rates, 
predominately from public hospitals.35 New South Wales, 
Queensland and Tasmania include 54% of the Austra-
lian population and New South Wales and Queensland 
encompass 52.8% of all Australian hospital beds. Hospital 
bed numbers in Tasmania are not publicly released to 
protect the confidentiality of the small number of private 
hospitals in Tasmania.
Patient and public involvement
No patient involved.
Ethical approval
Human Research Ethics Committees (HRECs) of all 
Australian states and territories provided ethical approval 
for the conduct of the study. Specifically, approval was 
provided by the New South Wales Population & Health 
Services Research Ethics Committee (ref# HREC/17/
CIPHS/58), The Australian Capital Territory Health 
Department HREC (ref# ETH.4.18.073E), Calvary 
Health Care Human Research Ethics Committee (ref# 
24-2018), Human Research Ethics Committee of the 
Northern Territory Department of Health (ref# 2018-
3183), Western Australian Department of Health HREC 
(ref# 2018/25) and the Tasmanian Department of Health 
HREC (ref# H0017507). States of Queensland, South 
Australia and Victoria accepted NSW HREC approval 
through a National Mutual HREC Acceptance Scheme. 
All HRECs granted a waiver of informed consent for the 
use of de- identified patient data.
Privacy and data security
De- identified study data will be securely stored at the 
Basil Hetzel Institute for Translational Research. A copy 
of the study data will be stored at the Secure Unified 
Research Environment (SURE). SURE is a highly secure, 
remote access data storage and analytic facility specifi-
cally designed for storage and analysis of large volumes 
of healthcare data.36 It uses extensive measures to ensure 
data security including data encryption, secure firewalls, 
password protection, logging of access to files and a 
‘curated gateway’ preventing data from being copied or 
moved out of the secure environment. Use of SURE facil-
itates secure access to study data for study investigators 
located throughout Australia.
Dissemination and translation
The study team involves stakeholder representatives 
and the study investigators are in advisory roles in safety 
and quality organisations such as the Quality and Safety 
Committee of the Royal Australasian College of Physi-
cians, Australian Patient Safety Foundation and ACSQHC. 
As the study progresses, the investigators will seek 
further engagement with state and federal stakeholders 
and professional bodies to facilitate dissemination and 
translation. We will also establish an independent Study 
Advisory Panel which will include stakeholders’ involve-
ment. This panel will meet two times a year and provide 
independent study advice and guidance. This provides a 
format for continued engagement of stakeholders as the 
study progresses, gains buy- in and creates a mechanism 
for the investigators to address stakeholder priorities and 
concerns. The findings will also be disseminated through 
scientific publications and briefing documents. Plain 
language summaries and infographics will also be used to 
promote research outcomes to the wider community via 
media releases and social media.
DISCUSSION
In Australia, like other countries with comparable highly 
developed healthcare systems, there are concerns about 
the safety and quality of, and potential variations in, 
hospital care. Harms associated with hospital care are 
poorly reported, partly because of the inability to capture 
adverse outcomes after discharge. Consequently, there 
are no national studies of post- discharge adverse events, 
deaths or readmissions. The avoidable adverse outcomes 
and associated healthcare costs are uncertain and 
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whether these vary among hospitals, suggesting variation 
in care quality, is unknown. The SAFER Hospitals study 
purports to answer these questions and benefit the Austra-
lian community by (1) informing and prioritising target 
conditions for large- scale quality improvement efforts; 
(2) developing and supporting the implementation of 
standardised methods for hospitals to routinely measure 
these outcomes and (3) facilitating policy changes such as 
public reporting efforts and innovative funding models to 
incentivise safer and more effective care. National studies 
of adverse outcomes are largely limited to North America 
and there is considerable interest in the generalisability 
of these outcomes to other health systems. Therefore, the 
outcomes of this study are likely to have broad relevance 
to the international literature.
This study has important limitations that need consider-
ation. The study data are linked only within each state and 
territory, except for cross- jurisdictional linkage between 
the state of New South Wales and Australian Capital Terri-
tory, and between South Australia and Northern Terri-
tory. While this may limit the ability to track outcomes 
for patients who are transferred across state borders, 
prior studies show that such transfers involve <3% of all 
patients and hence the likely impact on our outcome 
measurements will be small.37 Moreover, we limit our 
analyses to patients residents within each jurisdiction 
and exclude out- of- state residents to further minimise 
potential error. Our study is based on routinely collected 
administrative data which is less granular and potentially 
less accurate than data collected specifically for clin-
ical research or quality registries. While well- developed 
standards for coding of clinical diagnoses exist, retro-
spective coding of diagnoses depends on the diagnoses 
being recorded in the patient’s medical record, rather 
than based on the prospective application of external 
criteria, as would occur in a clinical trial. Routinely 
collected hospitalisation data also do not capture in- hos-
pital medication use or the results of investigations such 
as pathology results. Nevertheless, validation studies have 
shown relatively good accuracy of diagnoses and proce-
dures coding within administrative data compared with 
medical records.21 Linking routinely collected data is also 
the most accurate method for tracking post- discharge 
outcomes of care. It is not feasible to collect detailed indi-
vidual patient data at a national scale and thus an observa-
tional study using routinely collected data is the suitable 
data source for this purpose. South Australia, Tasmania 
and the Northern Territory do not release private 
hospital data to researchers although the impact on the 
study is likely to be small as most acute care in Australia 
is provided by public hospitals. These states only account 
for about 10% of the overall population. Furthermore, 
private hospitals in these states encompass a small propor-
tion of overall hospital beds. For example, those in South 
Australia form 2% of all hospital beds in Australia and 
the number of private hospital beds in Northern Terri-
tory and Tasmania is not publicly released to protect the 
confidentiality of the small number of private hospitals 
in these regions.19 Socioeconomic status may influence 
patient outcomes although socioeconomic characteris-
tics are not routinely collected in the hospital Admitted 
Patient Data Collections.
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